GED Iberian Fund has sold 4.1% of Corporación Dermoestética for EUR 15m through the company’s recent IPO. GED has trebled the value of its initial stake and achieved IRR of 40% on the investment.
Buyout and exit volume dropped dramatically in the first half of 2020, while GPs are doubling down on technology-driven strategies
Also backing the biotech startup were the Zürcher Kantonalbank and Greencross Medical Science Corp
Company plans to use the fresh capital to further expand, develop new features and scale up its team
EVentures, 468 Capital and HV Holtzbrinck back the round for the climate change mitigation app